Skip to content
10-Q

Quarterly Report

Kura Oncology, Inc. KURA

0001193125-25-263589

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 87.02M sh
Shares Diluted Q3 2025 · Sep 30, 2025 87.65M sh
Shares Diluted Q3 2025 · Sep 30, 2025 87.55M sh
Shares Diluted Q3 2025 · Sep 30, 2024 86.95M sh
Shares Diluted Q3 2025 · Sep 30, 2024 85.83M sh
Capex Q3 2025 · Sep 30, 2025 $4.32M
Capex Q3 2025 · Sep 30, 2024 $100K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$181.33M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$134.81M
Long Term Debt Q3 2025 · Sep 30, 2025 $5.34M
Long Term Debt Q3 2025 · Dec 31, 2024 $6.92M
Short Term Debt Q3 2025 · Sep 30, 2025 $4.34M
Short Term Debt Q3 2025 · Dec 31, 2024 $2.61M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $95.29M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $224.46M
Stockholders Equity Q3 2025 · Sep 30, 2025 $242.54M
Stockholders Equity Q3 2025 · Jun 30, 2025 $305.49M
Stockholders Equity Q3 2025 · Mar 31, 2025 $364.41M
Stockholders Equity Q3 2025 · Dec 31, 2024 $413.64M
Stockholders Equity Q3 2025 · Sep 30, 2024 $423.77M
Stockholders Equity Q3 2025 · Jun 30, 2024 $466.07M
Stockholders Equity Q3 2025 · Mar 31, 2024 $505.08M
Stockholders Equity Q3 2025 · Dec 31, 2023 $397.27M
Current Liabilities Q3 2025 · Sep 30, 2025 $121.3M
Current Liabilities Q3 2025 · Dec 31, 2024 $78.71M
Total Liabilities Q3 2025 · Sep 30, 2025 $406.84M
Total Liabilities Q3 2025 · Dec 31, 2024 $346.52M
Current Assets Q3 2025 · Sep 30, 2025 $620.66M
Current Assets Q3 2025 · Dec 31, 2024 $744.83M
Total Assets Q3 2025 · Sep 30, 2025 $649.38M
Total Assets Q3 2025 · Dec 31, 2024 $760.16M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.85
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.80
Eps Basic Q3 2025 · Sep 30, 2025 −$0.85
Eps Basic Q3 2025 · Sep 30, 2025 −$2.26
Eps Basic Q3 2025 · Sep 30, 2024 −$0.63
Eps Basic Q3 2025 · Sep 30, 2024 −$1.80
Rd Expense Q3 2025 · Sep 30, 2025 $67.91M
Rd Expense Q3 2025 · Sep 30, 2025 $186.67M
Rd Expense Q3 2025 · Sep 30, 2024 $41.71M
Rd Expense Q3 2025 · Sep 30, 2024 $117.7M
Net Income Q3 2025 · Sep 30, 2025 −$74.12M
Net Income Q3 2025 · Sep 30, 2025 −$197.67M
Net Income Q3 2025 · Jun 30, 2025 −$66.12M
Net Income Q3 2025 · Mar 31, 2025 −$57.43M
Net Income Q3 2025 · Sep 30, 2024 −$54.4M
Net Income Q3 2025 · Sep 30, 2024 −$154.77M
Net Income Q3 2025 · Jun 30, 2024 −$50.84M
Net Income Q3 2025 · Mar 31, 2024 −$49.53M
Operating Income Q3 2025 · Sep 30, 2025 −$80M
Operating Income Q3 2025 · Sep 30, 2025 −$217.36M
Operating Income Q3 2025 · Sep 30, 2024 −$59.88M
Operating Income Q3 2025 · Sep 30, 2024 −$170.74M
Revenue Q3 2025 · Sep 30, 2025 $20.75M
Revenue Q3 2025 · Sep 30, 2025 $50.15M